Michael Rayden News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Rayden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Rayden Today - Breaking & Trending Today

Dr Verschraegen on Toxicities Associated with Single-agent vs Doublet Immunotherapy in Melanoma

Published: April 14, 2023

Claire F. Verschraegen, MD, discusses adverse effects that are commonly associated with the use of single-agent nivolumab vs the combination of ipilimumab plus nivolumab in melanoma.

Source: onclive.com

Related Topics:

Diane NyeMichael RaydenClairef VerschraegenOhio State University College Of MedicineOhio State University Comprehensive Cancer CenterDivision Of Medical OncologyInnovative Cancer ResearchMedical OncologyOhio State University CollegeMelanoma Amp Skin CancerSingle AgentAdverse EffectsThyroid DysfunctionInsulin DeficiencyGrade 3 Or 4 Aes